The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease

New England Journal of Medicine

Volumn 335, Issue 24, 1996, Pages 1792-1798

  Joseph, Anne M ^a,b   Norman, Suzanne M ^b   Ferry, Linda H ^b   Prochazka, Allan V ^b   Westman, Eric C ^c   Steele, Bonnie G ^b   Sherman, Scott E ^b   Cleveland, Minot ^d   Antonnucio, David O ^e   Hartman, Neil ^b   Mcgovern, Paul G ^f  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

^d PORTLAND VA MEDICAL CENTER   (United States)

^e VA Sierra Nevada Health Care System   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HEART ARREST; HEART ARRHYTHMIA; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN MANIFESTATION; SLEEP DISORDER; SMOKING CESSATION; TRANSDERMAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARDIOVASCULAR DISEASES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 10544241545     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199612123352402     Document Type: Article

References (39)

1. Department of Health and Human Services. The health consequences of smoking: cardiovascular disease: a report of the Surgeon General. Washington, D.C.: Government Printing Office, 1983. (DHHS publication no. (PHS) 84-50204.)
2. Idem. The health benefits of smoking cessation: a report of the Surgeon General. Washington, D.C.; Government Printing Office, 1990. (DHHS publication no. (CDC) 90-8416.)
3. Fiore MC, Smith SS, Jorenby DE, Baker TB. The effectiveness of the nicotine patch for smoking cessation: a meta-analysis. JAMA 1994;271:1940-7.
4. Fiore MC, Bailey WC, Cohen SJ, et al. Smoking cessation: clinical practice guideline no. 18. Washington, D.C.: Government Printing Office, 1996. (AHCPR publication no. 96-0692.)
5. Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease. Nicotine replacement therapy for patients with coronary artery disease. Arch Intern Med 1994;154:989-95.
6. Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 1984;319:1318-30.
7. Kaijser L, Berglund B. Effect of nicotine on coronary blood-flow in man. Clin Physiol 1985;5:541-52.
8. Allred EN, Bleecker ER, Chaitman BR, et al. Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease. N Engl J Med 1989;321:1426-32. [Erratum, N Engl J Med 1990;322:1019.]
9. Benowitz NL, Fitzgerald GA, Wilson M, Zhang Q. Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol 1993;22:1159-67.
10. Allen SS, Hatsukami D, Gorsline J. Cholesterol changes in smoking cessation using the transdermal nicotine system: Transdermal Nicotine Study Group. Prev Med 1994;23:190-6.
11. 2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N Engl J Med 1995;332:1198-203.
12. Gillum RF, Ingram DD, Makuc DM. White blood cell count and stroke incidence and death: the NHANES I epidemiologic follow-up study. Am J Epidemiol 1994;139:894-902.
13. Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation: six-month results from two multicenter controlled clinical trials. JAMA 1991;266:3133-8.
14. Joseph AM, Westman EC. Transdermal nicotine therapy for older, medically ill patients: a pilot study. J Gen Intern Med 1995;10:Suppl:101. abstract.
15. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study. JAMA 1994;272:1497-505.
16. Rigotti NA, Eagle KA. Atrial fibrillation while chewing nicotine gum. JAMA 1986;255:1018.
17. Stewart PM, Catterall JR. Chronic nicotine ingestion and atrial fibrillation. Br Heart J 1985;54:222-3.
18. Dacosta A, Guy JM, Tardy B, et al. Myocardial infarction and nicotine patch: a contributing or causative factor? Eur Heart J 1993;14:1709-11.
19. Warner JG Jr, Little WC. Myocardial infarction in a patient who smoked while wearing a nicotine patch. Ann Intern Med 1994;120:695.
20. Ottervanger JP, Festen JM, de Vries AG, Stricker BH. Acute myocardial infarction while using the nicotine patch. Chest 1995;107:1765-6.
21. Hwang SL, Waldholt M. Heart attacks reported in patch users still smoking. Wall Street Journal. June 19,1992:B1.
22. Fredrickson PA, Hurt RD, Lee GM, et al. High dose transdermal nicotine therapy for heavy smokers: safety, tolerability and measurement of nicotine and cotinine levels. Psychopharmacology 1995;122:215-22.
23. Pierce JR Jr. Stroke following application of a nicotine patch. Ann Pharmacother 1994;28:402.
24. Jackson M. Cerebral arterial narrowing with nicotine patch. Lancet 1993;342:236-7.
25. Arnaot MR. Treating heart disease: nicotine patches may not be safe. BMJ 1995;310:663-4.
26. Clearing the air: how to quit smoking . . . and quit for keeps. Bethesda, Md.: National Cancer Institute, 1993. (NIH publication no. 95-1647.)
27. Why do you smoke? Bethesda, Md.: National Cancer Institute, 1993. (NIH publication no. 94-1822.)
28. Tar, nicotine and carbon monoxide content of the smoke of 475 varieties of domestic cigarettes. Washington, D.C.: Federal Trade Commission, 1991.
29. Fagerström KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerström Tolerance Questionnaire. J Behav Med 1989;12: 159-82.
30. SAS/STAT user's guide, version 6. 4th ed. Vols. 1 and 2. Cary, N.C.: SAS Institute, 1989.
31. Taylor CB, Houston-Miller N, Killen JD, DeBusk RF. Smoking cessation after acute myocardial infarction: effects of a nurse-managed intervention. Ann Intern Med 1990;113:118-23.
32. Rigotti NA, McKool KM, Shiffman S. Predictors of smoking cessation after coronary artery bypass graft surgery: results of a randomized trial with 5-year follow-up. Ann Intern Med 1994;120:287-93.
33. DeBusk RF, Miller NH, Superko HR, et al. A case-management system for coronary risk factor modification after acute myocardial infarction. Ann Intern Med 1994;120:721-9.
34. Frid D, Ockene IS, Ockene JK, et al. Severity of angiographically proven coronary artery disease predicts smoking cessation. Am J Prev Med 1991;7:131-5.
35. FitzGerald GA, Oates JA, Nowak J. Cigarette smoking and hemostatic function. Am Heart J 1988;115:267-71.
36. Henningfield JE. Nicotine medications for smoking cessation. N Engl J Med 1995;333:1196-203.
37. Benowitz NL, Jacob P III. Intravenous nicotine replacement suppresses nicotine intake from cigarette smoking. J Pharmacol Exp Ther 1990; 254:1000-5.
38. Henningfield JE, Stapleton JM, Benowitz NL, Grayson RF, London ED. Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend 1993;33:23-9.
39. Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB. Predicting smoking cessation: who will quit with and without the nicotine patch. JAMA 1994;271:589-94.